Privia Health Group (NASDAQ:PRVA – Get Rating) had its target price increased by equities researchers at Canaccord Genuity Group from $29.00 to $40.00 in a research note issued on Wednesday, The Fly reports. Canaccord Genuity Group’s price objective suggests a potential upside of 37.36% from the stock’s current price.
Several other research analysts have also commented on PRVA. Canaccord Genuity Group cut their price target on shares of Privia Health Group from $50.00 to $44.00 and set a “buy” rating on the stock in a report on Thursday, March 24th. BTIG Research assumed coverage on shares of Privia Health Group in a report on Thursday, April 28th. They issued a “buy” rating and a $35.00 price target on the stock. Bank of America assumed coverage on shares of Privia Health Group in a report on Tuesday, May 3rd. They issued a “buy” rating and a $27.00 price target on the stock. SVB Leerink raised their price target on shares of Privia Health Group from $43.00 to $44.00 and gave the company an “outperform” rating in a report on Friday, March 25th. Finally, Guggenheim assumed coverage on shares of Privia Health Group in a report on Tuesday, March 29th. They issued a “buy” rating and a $35.00 price target on the stock. Eleven investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Privia Health Group presently has a consensus rating of “Buy” and a consensus target price of $38.45.
Shares of PRVA stock opened at $29.12 on Wednesday. The firm has a market cap of $3.16 billion, a P/E ratio of -14.27 and a beta of 1.68. Privia Health Group has a 1-year low of $17.99 and a 1-year high of $47.77. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.24 and a quick ratio of 2.24. The firm’s 50-day simple moving average is $24.88 and its 200-day simple moving average is $24.56.
In other news, CEO Matthew Shawn Morris sold 77,534 shares of the firm’s stock in a transaction that occurred on Thursday, June 23rd. The shares were sold at an average price of $29.41, for a total transaction of $2,280,274.94. Following the completion of the sale, the chief executive officer now owns 121,739 shares of the company’s stock, valued at $3,580,343.99. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Thomas Bartrum sold 10,000 shares of Privia Health Group stock in a transaction on Wednesday, April 20th. The stock was sold at an average price of $27.93, for a total transaction of $279,300.00. Following the completion of the transaction, the executive vice president now directly owns 27,391 shares of the company’s stock, valued at approximately $765,030.63. The disclosure for this sale can be found here. Insiders have sold 227,614 shares of company stock valued at $6,416,675 in the last three months. Corporate insiders own 57.60% of the company’s stock.
A number of institutional investors have recently added to or reduced their stakes in the business. Rockefeller Capital Management L.P. acquired a new position in Privia Health Group in the fourth quarter worth $25,000. First Horizon Advisors Inc. acquired a new position in Privia Health Group in the fourth quarter worth $26,000. FourThought Financial LLC boosted its holdings in Privia Health Group by 77.2% in the first quarter. FourThought Financial LLC now owns 2,417 shares of the company’s stock worth $65,000 after purchasing an additional 1,053 shares during the period. US Bancorp DE boosted its holdings in Privia Health Group by 8.8% in the first quarter. US Bancorp DE now owns 13,923 shares of the company’s stock worth $372,000 after purchasing an additional 1,131 shares during the period. Finally, Blair William & Co. IL boosted its holdings in Privia Health Group by 9.2% in the first quarter. Blair William & Co. IL now owns 17,412 shares of the company’s stock worth $465,000 after purchasing an additional 1,463 shares during the period. 63.77% of the stock is owned by hedge funds and other institutional investors.
Privia Health Group Company Profile (Get Rating)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Recommended Stories
Receive News & Ratings for Privia Health Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Privia Health Group and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
